June 17, 2020 / 11:47 AM / 15 days ago

BRIEF-Hookipa Announces FDA Clearance Of Ind Application For Hb-202/201 Clinical Trial To Treat Hpv-Positive Cancers

June 17 (Reuters) - HOOKIPA Pharma Inc:

* HOOKIPA ANNOUNCES FDA CLEARANCE OF ITS IND APPLICATION FOR HB-202/201 CLINICAL TRIAL TO TREAT HPV-POSITIVE CANCERS

* HOOKIPA PHARMA - IN 2021, HOOKIPA EXPECTS TO ALSO COMBINE HB-202/201 WITH AN APPROVED CHECKPOINT INHIBITOR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below